Država: Velika Britanija
Jezik: engleski
Izvor: MHRA (Medicines & Healthcare Products Regulatory Agency)
Ferrous gluconate
Strides Pharma UK Ltd
B03AA03
Ferrous gluconate
300mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 09010101; GTIN: 5031676004349 5031676001324
PATIENT INFORMATION LEAFLET FERROUS GLUCONATE 300MG TABLETS READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. ALWAYS TAKE THIS MEDICINE EXACTLY AS DESCRIBED IN THIS LEAFLET OR AS YOUR DOCTOR OR PHARMACIST HAS TOLD YOU. • KEEP THIS LEAFLET. YOU MAY NEED TO READ IT AGAIN. • IF YOU HAVE ANY FURTHER QUESTIONS, ASK YOUR DOCTOR OR PHARMACIST. • THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU ONLY. DO NOT PASS IT ON TO OTHERS. IT MAY HARM THEM, EVEN IF THEIR SIGNS OF ILLNESS ARE THE SAME AS YOURS. • IF YOU GET ANY SIDE EFFECTS TALK TO YOUR DOCTOR OR PHARMACIST. THIS INCLUDES ANY POSSIBLE SIDE EFFECTS NOT LISTED IN THIS LEAFLET. SEE SECTION 4. • YOU MUST TALK TO A DOCTOR IF YOU DO NOT FEEL BETTER OR IF YOU FEEL WORSE. WHAT IS IN THIS LEAFLET 1. What Ferrous Gluconate 300mg Tablets are and what they are used for 2. What you need to know before you take Ferrous Gluconate 300mg Tablets 3. How to take Ferrous Gluconate 300mg Tablets 4. Possible side effects 5. How to store Ferrous Gluconate 300mg Tablets 6. Contents of the pack and other information 1. 2. WHAT FERROUS GLUCONATE 300MG TABLETS ARE AND WHAT THEY ARE USED FOR Ferrous Gluconate 300mg Tablets are used for the treatment and prevention of iron deficiency. Ferrous Gluconate is a form of iron. Iron is necessary for the production of haemoglobin (protein in red blood cells), which carries oxygen around the body. Iron is involved in the formation of myoglobin, a pigment that stores oxygen in muscles for use during exercise. WHAT YOU NEED TO KNOW BEFORE YOU TAKE FERROUS GLUCONATE 300MG TABLETS DO NOT TAKE FERROUS GLUCONATE 300MG TABLETS: • if you are allergic (hypersensitive) to ferrous gluconate, medicines containing iron or any of the other ingredients in this medicine (See section 6) • if you have a build up of too much iron in the body (haemochromatosis) • if you suffer from iron storage (haemosiderosis) or absorption (haemoglobinuria) • if you have anaemia not caused by Iron defici Pročitajte cijeli dokument
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ferrous Gluconate Tablets BP 300 mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 300mg of the active substance ferrous gluconate Excipient(s) with known effect Sucrose Certolake ponceau 4R For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Coated tablet Red, circular, biconvex sugar-coated tablets. 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS Ferrous gluconate tablets 300 mg are indicated for the prevention and treatment of iron deficiency states. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology ADULTS, THE ELDERLY AND CHILDREN OVER 12 YEARS Prophylactic: 2 tablets daily Therapeutic: 4-6 tablets daily in divided doses CHILDREN (6-12 YEARS) Prophylactic: 1 or 2 tablets daily Therapeutic: 3 tablets daily in divided doses Ferrous Gluconate is not recommended in children under 6 years. Ferrous gluconate tablets are best taken about 1 hour before meals. Method of administration The route of administration for ferrous gluconate tablets is oral. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. Iron preparations are contraindicated in patients with haemochromatosis, iron storage or absorption diseases such as and haemosiderosis or haemoglobinuria. Iron is contraindicated in patients receiving repeated blood transfusions, or in patients receiving parenteral iron therapy or to patients with anaemias not produced by iron deficiency (some conditions, such as thalassemia may cause excess storage of iron). Alcoholism and hepatitis. Iron preparations are contraindicated in active peptic ulcer, regional enteritis and ulcerative colitis. Ferrous Gluconate Tablets should not be used in patients with anaemia not produced by iron deficiency unless iron deficiency is also present. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Large doses may have irritant/corrosive effect on gastro-intestinal mucosa which can lead to necrosis and perforation. Ferrous glu Pročitajte cijeli dokument